Search results for "NICOTINE"

showing 10 items of 145 documents

The Health Risks of Electronic Cigarettes Use in Adolescents

2020

The evidence to date suggests that vaping is not a safe alternative to smoking tobacco. This, coupled with the worrying trend of young nonsmokers being attracted to vaping, raises fears of yet another generation suffering from chronic lung disease and other acute and chronic health conditions. Finally, due to the insufficient regulations in several countries, up-to-date data on the prevalence of e-cigarette use and studies on the health's implications of their use are urgently needed to inform policy at a national and international level (ie, European Union). Pediatricians are typically on the front line for identifying emerging risks for children and adolescents ; therefore, they may effec…

HealthRisk Electronic Cigarette AdolescentsAdolescentbusiness.industryVapingAdolescent ; Electronic Nicotine Delivery Systems ; Humans ; Risk Factors ; VapingElectronic Nicotine Delivery Systemscigarettes childrenchildrenSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICARisk FactorsEnvironmental healthPediatrics Perinatology and Child HealthHumansMedicinebusinesscigarettesThe Journal of Pediatrics
researchProduct

Expression and function of the non-neuronal cholinergic system in endothelial cells

2003

Increasing evidence has shown the expression of the non-neuronal cholinergic system in endothelial cells. In the present experiments the expression of choline acetyltransferase (ChAT) was investigated in human endothelial cells by anti-ChAT immunohistochemistry and anti-ChAT immunofluorescence. Positive ChAT immunoreactivity was found in cultures of human umbilical endothelial cells (HUVEC) and a human angiosarcoma cell line (HAEND). In HUVEC and HAEND choline acetyltransferase activity and small amounts of acetylcholine were also detected. Positive ChAT-immunoreactivity was demonstrated in situ in endothelial cells of the human umbilical cord. In addition, in experiments with confocal lase…

LipopolysaccharidesNicotinePathologymedicine.medical_specialtyEndotheliumPhysostigmineeducationHuman skinBiologyImmunofluorescenceGeneral Biochemistry Genetics and Molecular BiologyCell LineCholine O-Acetyltransferasemental disordersTumor Cells CulturedmedicineHumansNicotinic AgonistsGeneral Pharmacology Toxicology and PharmaceuticsChromatography High Pressure LiquidMicroscopy Confocalmedicine.diagnostic_testCell adhesion moleculeAntibodies MonoclonalGeneral MedicineImmunohistochemistryCholine acetyltransferaseAcetylcholinehumanitiesCell biologymedicine.anatomical_structureNicotinic agonistnervous systemCell cultureCholinesterase InhibitorsEndothelium VascularCell Adhesion MoleculesAcetylcholineSignal Transductionmedicine.drugLife Sciences
researchProduct

The effects of social anxiety on alcohol and cigarette use across adolescence: Results from a longitudinal twin study in Finland.

2016

Conflicting reports exist on the direction of the relationship between social anxiety (SA) and alcohol/cigarette use (AU/CU) and alcohol/nicotine dependence (AD/ND), with both positive and negative associations reported. A prospective, longitudinal sample of Finnish twins (n = 1,906) was used to test potential explanations for these discrepancies. Specifically, this study used peer, parent, and teacher ratings of SA, and a clinical interview screening item for social anxiety disorder (SAD-Sc) to examine associations between SA and AU/CU and AD/ND from early adolescence into young adulthood. Peer-rated SA was negatively associated with AU, CU, and AD from age 14 through age 22, implying a pr…

Male030508 substance abuseMedicine (miscellaneous)Nicotine0302 clinical medicineTwins DizygoticLongitudinal StudiesProspective StudiesadolescentsYoung adultChildFinlandta515media_commonalcoholSmokingSocial anxietyTobacco Use Disorderta3142twinsAlcoholismPsychiatry and Mental healthClinical PsychologyFemale0305 other medical sciencePsychologymedicine.drugAdultmedicine.medical_specialtyAdolescentAlcohol Drinkingmedia_common.quotation_subjectnikotiiniContext (language use)ArticlePeer GroupYoung Adult03 medical and health sciencesmedicineHumansRisk factorPsychiatryPhobia SocialPeer groupTwins MonozygoticAbstinenceTwin study030227 psychiatrykaksosetGene-Environment InteractionSelf Reportsocial anxietynicotinePsychology of Addictive Behaviors
researchProduct

Effects of acute administration of bupropion on behavior in the elevated plus-maze test by NMRI mice

2004

Bupropion attenuates some symptoms of nicotine abstinence, although its effects on anxiety are unclear. The present study investigates acute effects of bupropion (5, 10, 20 and 40 mg/kg) on anxiety as expressed in the elevated plus-maze test in male NMRI mice. Given the influence of locomotion in this test, effects of bupropion were also evaluated in an actimeter. Spontaneous motor activity remained significantly increased in mice treated with 10, 20 and 40 mg/kg of bupropion during the 60 min recorded. Results from the elevated plus-maze showed that 20 mg/kg increased total arm entries and 40 mg/kg increased total and open arm entries. Although the increase in the number of visits to the o…

MaleAcute effectsElevated plus mazemedicine.drug_classmedia_common.quotation_subjectAnxietyMotor ActivityPharmacologyAnxiolyticNicotineMicemedicineAnimalsBupropionBiological Psychiatrymedia_commonPharmacologyBupropionBehavior AnimalDose-Response Relationship DrugAbstinenceNmri miceAntidepressive Agents Second-GenerationAnxietymedicine.symptomPsychologymedicine.drugProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Effects of Early Training and Nicotine Treatment on the Performance of Male NMRI Mice in the Water Maze

2004

This research aimed to evaluate the effect of nicotine treatment and prior training on a spatial learning task in differently aged NMRI male mice. In a longitudinal study, mice were randomly assigned to one of 14 experimental groups receiving different combinations of chronically injected nicotine (0.35 mg/kg) administered for 10 days (5 days before and during 5 days acquisition of task) or control treatments and training in the water maze at different ages. The mice displayed shorter escape latencies when evaluated at 6 and 10 months than when tested in this task at 2 months for the first time, demonstrating that early training preserves performance in the water maze up to 8 months after t…

MaleAgingNicotineMaze learningMale miceWater mazeArticlelcsh:RC321-571Developmental psychologyNicotineMiceMemorymedicineAnimalsLongitudinal StudiesNicotinic AgonistsMaze Learninglcsh:Neurosciences. Biological psychiatry. NeuropsychiatryNicotinic agonistNeurologyNmri miceReference memoryAnesthesiaSpatial learningNeurology (clinical)Psychologymedicine.drugNeural Plasticity
researchProduct

Bupropion induced changes in exploratory and anxiety-like behaviour in NMRI male mice depends on the age

2013

The aim of this study was to assess the effects of the antidepressant bupropion on anxiety and novelty-seeking in adolescent mice of different ages and adults. Behavioural differences between early adolescent, late adolescent and adult NMRI mice were measured both in the elevated plus-maze and the hole-board tasks following acute administration of bupropion (5, 10, 15, 20 mg/kg) or saline. In the plus maze test, early and late adolescent mice treated with bupropion (10, 15 mg/kg, respectively) had lower percentages of entries in the open-arms compared to their vehicle controls. Adult mice treated with bupropion did not differ from their vehicle controls. These results suggest that the effec…

MaleAgingmedicine.medical_specialtyElevated plus mazeHole-boardDEFICIT HYPERACTIVITY DISORDERmedicine.medical_treatmentAnxietySUBSTANCE USE DISORDERSINDIVIDUAL-DIFFERENCESHOLE-BOARD TESTMiceBehavioral NeuroscienceADULT RATSInternal medicinemedicineAnimalsSOCIAL-BEHAVIORMaze LearningPsychiatryBupropionBupropionHole-board testDose-Response Relationship DrugLOCOMOTOR-ACTIVITYNovelty seekingELEVATED PLUS-MAZEGeneral MedicineSMOKING-CESSATIONNICOTINE DEPENDENCEAdolescenceEndocrinologyNovelty-seekingAnxiogenicExploratory BehaviorAntidepressive Agents Second-GenerationSmoking cessationAntidepressantAnxietyAnimal Science and Zoologymedicine.symptomPsychologypsychological phenomena and processesmedicine.drugBehavioural Processes
researchProduct

Effects of bupropion, alone or coadministered with nicotine, on social behavior in mice

2008

Bupropion, administered alone or combined with nicotine, is presently used to treat nicotine dependence. Despite experimental evidence of the complex behavioral actions of this drug, there have been little data reported about its effects on social behavior. Our main aim was to investigate the effects of acute administration of bupropion, alone or plus nicotine, on social interaction in mice. OF1 group-housed male mice were confronted in a neutral cage with an anosmic opponent during a 10 minutes encounter. Time allocated to body care and digging was reduced by administration of bupropion (40 mg/kg) both when administered alone and with nicotine (1 and 0.5 mg/kg). The lowest dose of bupropio…

MaleDrugNicotinemedicine.drug_classmedia_common.quotation_subjectMedicine (miscellaneous)Male miceAnxietyPharmacologyAnxiolyticDrug Administration ScheduleNicotineMiceDopamine Uptake Inhibitorsmental disordersmedicineAnimalsSocial BehaviorNicotine dependenceBupropionmedia_commonPharmacologyBupropionBehavior AnimalLow doseTobacco Use Disordermedicine.diseaseGanglionic StimulantsAggressionPsychiatry and Mental healthExploratory BehaviorPsychologymedicine.drugAddiction Biology
researchProduct

Effects of co-administration of bupropion and nicotinic agonists on the elevated plus-maze test in mice

2005

There is evidence that the cholinergic nicotinic system is involved in the modulation of anxiety. Anxiolytic and anxiogenic effects of nicotine agonists have been reported in mice. Bupropion is an antidepressant drug which may alleviate some symptoms of nicotine withdrawal, although its effects on anxiety are not clear. It has been suggested that the interaction between bupropion and nicotinic mechanisms could be complex. The aim of the present study was to investigate acute effects of co-administration of bupropion and nicotinic agonists on the elevated plus-maze test in NMRI mice. Effects of nicotine, lobeline, and cytisine (0.35 and 0.175 mg/kg), administered alone or combined with bupro…

MaleElevated plus mazemedicine.drug_classPharmacologyAnxiolyticNicotineMicechemistry.chemical_compoundDopamine Uptake Inhibitorsmental disordersmedicineAnimalsLobelineNicotinic AgonistsMaze LearningBupropionBiological PsychiatryPharmacologyBupropionAnalysis of VarianceBehavior AnimalDose-Response Relationship Drugbusiness.industrymedicine.diseaseDrug CombinationsNicotinic agonistNicotine withdrawalchemistryAnxiogenicbusinesspsychological phenomena and processesmedicine.drugProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Transcription factor gene expression profiling after acute intermittent nicotine treatment in the rat cerebral cortex

2004

Several studies in different in vitro and in vivo models have demonstrated neuroprotective effects of nicotinic receptor agonists and indirect trophic actions of nicotine on brain are suggested from observations describing nicotine as a cognitive enhancer by increasing vigilance and improving learning and memory. While an increasing number of studies have given evidence of neuroprotective and neurotrophic effects of nicotine treatment, the molecular mechanism mediating the neurotrophic effects of nicotine are not fully understood. Previously in an analysis of several neurotrophic factors as possible mediators of nicotine-induced neuroprotection and/or neurotrophic effects we could reveal th…

MaleNicotineGene ExpressionBiologyNeuroprotectionNicotineCerebral Cortex/drug effectNeurotrophic factorsmedicineAnimalsNicotinic AgonistsRats WistarIn Situ HybridizationOligonucleotide Array Sequence AnalysisCerebral CortexMicroarray analysis techniquesGene Expression ProfilingGeneral NeuroscienceRatsGene expression profilingNicotinic agonistNicotine/pharmacology Nicotinic Agonistsbiology.proteinGene Expression/drug effectImmediate early geneNeuroscienceTranscription Factorsmedicine.drugNeurotrophinNeuroscience
researchProduct

Critical role of nitric oxide on nicotine-induced hyperactivation of dopaminergic nigrostriatal system: electrophysiological and neurochemical eviden…

2010

Nicotine, the main psychoactive ingredient in tobacco, stimulates dopamine (DA) function, increasing DA neuronal activity and DA release. DA is involved in both motor control and in the rewarding and reinforcing effects of nicotine; however, the complete understanding of its molecular mechanisms is yet to be attained. Substantial evidence indicates that the reinforcing properties of drugs of abuse, including nicotine, can be affected by the nitric oxide (NO) system, which may act by modulating central dopaminergic function. In this study, using single cell recordings in vivo coupled with microiontophoresis and microdialysis in freely moving animals, the role of NO signaling on the hyperacti…

MaleNicotineIndazolesTime FactorsDopamineMicrodialysisAction PotentialsArginineSettore BIO/09 - FisiologiaCorpus striatumRats Sprague-DawleyAnimalsDrug InteractionsNicotinic Agonistsnigrostriatal systemEnzyme InhibitorsNeuronsAnalysis of VarianceDose-Response Relationship DrugResearchNitric oxideSubstantia NigraratsNG-Nitroarginine Methyl Esternervous system34-Dihydroxyphenylacetic Aciddopamine
researchProduct